Literature DB >> 20489605

Pharmacokinetics and pharmacodynamics in critically ill patients.

Julie M Varghese1, Jason A Roberts, Jeffrey Lipman.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to highlight the recently published studies in the area of pharmacokinetics and pharmacodynamics in critically ill patients and ascertain the relevance to clinical practice. RECENT
FINDINGS: The majority of the published studies in this area were related to antibiotics and this will form the main focus of this review. A number of studies have focused on antibiotic concentrations at various target sites of infection or other tissue sites including cerebrospinal fluid, peritoneal fluid and burns tissues. The administration of time-dependent antibiotics using continuous infusion has also been the subject of recently published studies which support the superior achievement of pharmacodynamic targets using continuous infusion compared with bolus dosing. Antibiotic dosing during renal replacement therapies, mainly during extended daily dialysis (EDD) and during other forms of extracorporeal techniques including extracorporeal membrane oxygenation (ECMO), have also been described in a few recent studies and case reports.
SUMMARY: Studies have shown that critically ill patients display large variations in pharmacokinetics mainly due to altered pathophysiology. An understanding of the pathophysiological changes that occur in critically ill patients is essential to optimize dosing particularly to achieve the pharmacodynamic targets for antibiotics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20489605     DOI: 10.1097/ACO.0b013e328339ef0a

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  13 in total

1.  Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Authors:  Seth R Bauer; Charbel Salem; Michael J Connor; Joseph Groszek; Maria E Taylor; Peilin Wei; Ashita J Tolwani; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia.

Authors:  Kristina Öbrink-Hansen; Tore Forsingdal Hardlei; Birgitte Brock; Søren Jensen-Fangel; Marianne Kragh Thomsen; Eskild Petersen; Mads Kreilgaard
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

Review 3.  Right first time!

Authors:  Emine Alp
Journal:  Ann Transl Med       Date:  2016-09

4.  Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial.

Authors:  Thor W Bjelland; Ola Dale; Kjell Kaisen; Bjørn O Haugen; Stian Lydersen; Kristian Strand; Pål Klepstad
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

5.  Cardiac Arrest Treatment Center Differences in Sedation and Analgesia Dosing During Targeted Temperature Management.

Authors:  Ameldina Ceric; Teresa L May; Anna Lybeck; Tobias Cronberg; David B Seder; Richard R Riker; Christian Hassager; Jesper Kjaergaard; Zana Haxhija; Hans Friberg; Josef Dankiewicz; Niklas Nielsen
Journal:  Neurocrit Care       Date:  2022-07-28       Impact factor: 3.532

6.  New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease.

Authors:  Gauri G Rao; Neang S Ly; Curtis E Haas; Samira Garonzik; Alan Forrest; Jurgen B Bulitta; Pamela A Kelchlin; Patricia N Holden; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 7.  Antimicrobial dosing in acute renal replacement.

Authors:  William H Fissell
Journal:  Adv Chronic Kidney Dis       Date:  2013-01       Impact factor: 3.620

8.  Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study.

Authors:  Idoia Bilbao-Meseguer; Helena Barrasa; Alicia Rodríguez-Gascón; Eduardo Asín-Prieto; Javier Maynar; José Ángel Sánchez-Izquierdo; María Ángeles Solinís; Arantxazu Isla
Journal:  J Intensive Care       Date:  2022-04-21

9.  Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies.

Authors:  Anthony J Garcia-Prats; Nicole Salazar-Austin; James H Conway; Kendra Radtke; Sylvia M LaCourse; Elizabeth Maleche-Obimbo; Anneke C Hesseling; Rada M Savic; Sharon Nachman
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

10.  Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; Jason A Roberts; Charles I Mcdonald; Stephanie Fisquet; Adrian G Barnett; Daniel V Mullany; Sussan Ghassabian; Steven C Wallis; Yoke L Fung; Maree T Smith; John F Fraser
Journal:  Crit Care       Date:  2012-10-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.